Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting
{{output}}
Background: The evidence base of tisagenlecleucel is uncertain. Objective: To evaluate the cost-effectiveness of tisagenlecleucel. To conduct e... ...
